Skip to main content
. 2024 Mar 15;46(3):714–726. doi: 10.1007/s11096-024-01708-y

Table 3.

Five highest ranked categories for “incentives” with corresponding mechanisms

Category mechanism Sum of votes Frequency of votes Relative importance* Summed up relative importance Linked to implementation outcomes
Chamber employees
Process support 50.0 Adoption, feasibility
Supporting the infrastructural development of MRs (incl. initial phase) (C1) 20 4 33.3
Providing pre-phrased process descriptions as part of the quality management process (C1) 10 4 16.7
Benefit for pharmacy 48.3 Sustainability
Inspiring young colleagues to take up community pharmacy (C1) 8 3 13.3
Increasing employees' job-satisfaction (C1) 7 2 11.7
Stressing advantages of MRs and to owners e.g., staff loyalty (C2) 6 2 10.0
Facilitating recruitment of junior staff (C2) 2 2 3.3
Generating more profit using specialist knowledge (C2) 3 1 5.0
Potential of MR related work to be carried out at home (C2) 3 1 5.0
Increase visibility of role models 21.7 Appropriateness, adoption
Making role models visible (e.g., via social media posts, newsletters) (C2) 13 3 21.7
Involving owners 16.7 Appropriateness, adoption
Finding ways of reaching owners (C2) 10 2 16.7
Financial viability 15.0 Cost
Reducing costs of materials (C1) 9 3 15.0
Owners
Software 95.3 Appropriateness, adoption, fidelity
Integrating MR software within pharmacy management software (O1) 15 4 25.0
Providing maximal IT support for the entire process (O1) 15 4 25.0
Providing access to fit-for-purpose software (O2) 16 4 21.3
Providing easy to use appointment software (clever & simple) (O2) 8 3 10.7
Providing simple, intuitive usable software (O2) 10 2 13.3
Financial viability 25.0 Adoption, cost
Offering higher remuneration during the initial phase (external incentive) (O1) 15 4 25.0
Materials 17.3 Appropriateness
Providing a start-up package (materials) (O2) 13 4 17.3
Reduction of bureaucracy 16.0 Appropriateness, adoption, feasibility
Reducing bureaucracy and documentation (O2) 7 3 9.3
Simplifying customers' input into documentation (O2) 5 2 6.7
Larger target group 13.3
Establishing the legal base to provide MRs for patients in care homes (O1) 8 3 13.3